← Scroll for more →
Financial Statements — NAMI
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|
| Cash & Equivalents | 9.19 | 7.70 | 12.68 |
| Short-term Investments | 2.15 | 31.79 | 1.25 |
| Accounts Receivable | 3.89 | 43.14 | 53.84 |
| Inventory | 0.33 | 4.12 | 0.11 |
| Total Current Assets | 120.60 | 20.61 | 162.59 |
| Property, Plant & Equipment | 1.75 | 0.30 | 0.27 |
| Intangible Assets | 6.45 | 9.35 | 8.46 |
| Total Non-current Assets | 71.67 | 96.51 | 11.06 |
| Total Assets | 192.26 | 34.08 | 243.28 |
| Accounts Payable | 30.59 | 58.77 | 38.02 |
| Short-term Debt | 15.00 | -- | -- |
| Total Current Liabilities | 78.85 | 12.36 | 10.25 |
| Total Non-current Liabilities | 0.52 | 0.48 | 0.64 |
| Total Liabilities | 11.79 | 12.84 | 79.45 |
| Retained Earnings | (238.12) | (23.02) | (19.67) |
| Total Stockholder Equity | 11.99 | 119.60 | 131.97 |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 |
|---|---|
| Total Revenue | 29.11 |
| Cost of Revenue | 24.78 |
| Gross Profit | 4.32 |
| Research & Development | 3.54 |
| Selling, General & Admin | 2.89 |
| Total Operating Expenses | 54.88 |
| Operating Income | (3.34) |
| Pretax Income | (2.94) |
| Tax Provision | 0.02 |
| Net Income | (21.29) |
| Basic EPS | 0.00 |
| Diluted EPS | 0.00 |
← Scroll for more columns →
Cash Flow Statement
(in millions CNY)| Metric | Q2 2025 |
|---|---|
| Operating Cash Flow | 14.22 |
| Capital Expenditures | 0.95 |
| Free Cash Flow* | 13.27 |
| Investing Cash Flow | (55.95) |
| Financing Cash Flow | 0.49 |
← Scroll for more columns →
* Derived from reported values